These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24168921)

  • 1. Consolidation therapy after concurrent radiochemotherapy? Still unclear who may potentially benefit!
    Jeremic B; Langenhoven L
    Lung Cancer; 2013 Dec; 82(3):509. PubMed ID: 24168921
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma.
    Sun Y; Duan Q; Chen X; Chen W; Jin X; Wu R
    Clin Transl Oncol; 2017 Dec; 19(12):1498-1506. PubMed ID: 28589432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Response to Pembrolizumab in a Critically Ill Mechanically Ventilated Patient with New Diagnosis of NSCLC.
    McLoughlin EM; Larner JM; Bergman MP; Stelow EB; Brady K; Lynch AC; Abraham RS; Gentzler RD
    J Thorac Oncol; 2019 Sep; 14(9):e193-e195. PubMed ID: 31445732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non-small cell lung carcinoma. Integrated therapy: surgery plus radiotherapy and radiochemotherapy].
    Pergolizzi S; De Renzis C
    Suppl Tumori; 2004; 3(2):S27-8. PubMed ID: 15067961
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Fabre E; Pécuchet N; Cadranel J
    Bull Cancer; 2016 Nov; 103 Suppl 1():S138-S143. PubMed ID: 28057177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound neutropenia related to consolidation durvalumab treatment following concurrent radiochemotherapy in a patient with stage III non-small‑cell lung cancer.
    Bandura A; Kurlapski M; Kamińska M; Dziadziuszko R; Jassem J
    Pol Arch Intern Med; 2022 Feb; 132(2):. PubMed ID: 34851079
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer.
    Lind JS; Senan S; Smit EF
    J Clin Oncol; 2012 Mar; 30(8):e104-8. PubMed ID: 22331948
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity in medicine.
    Saeed M
    J Pak Med Assoc; 2004 Sep; 54(9):496-7. PubMed ID: 15518378
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer].
    Zapata E; Mennecier B; Leduc C; Chatron E; Quoix E
    Rev Pneumol Clin; 2016 Oct; 72(5):300-304. PubMed ID: 27561974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard treatment option in stage III non-small-cell lung cancer: case against trimodal therapy and consolidation drug therapy.
    Jeremić B
    Clin Lung Cancer; 2015 Mar; 16(2):80-5. PubMed ID: 25450877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer.
    Harris JP; Patel MI; Loo BW; Wakelee HA; Diehn M
    Lung Cancer; 2017 Jun; 108():173-182. PubMed ID: 28625632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiochemotherapy in non-small-cell lung cancer].
    Swartman B
    Med Klin Intensivmed Notfmed; 2011 Nov; 106(3):212-7. PubMed ID: 22068757
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves breakthrough immunotherapy for patients with non-small-cell lung cancer.
    Printz C
    Cancer; 2017 Jan; 123(2):191. PubMed ID: 28067949
    [No Abstract]   [Full Text] [Related]  

  • 15. PL03.05 An intergroup randomized phase III comparison of standard-dose (60 Gy) vs high-dose (74 Gy) chemoradiotherapy (CRT) +/- cetuximab (cetux) for stage III non-small cell lung cancer (NSCLC): results on cetux from RTOG 0617.
    Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 1):2-4. PubMed ID: 24852394
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.
    Takayama K; Inoue K; Tokunaga S; Matsumoto T; Oshima T; Kawasaki M; Imanaga T; Kuba M; Takeshita M; Harada T; Shioyama Y; Nakanishi Y
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1353-9. PubMed ID: 24166107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concurrent induction chemo-radiotherapy followed by surgery in lung cancer].
    Katakami N
    Nihon Rinsho; 2002 May; 60 Suppl 5():450-4. PubMed ID: 12101712
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01.
    Fournel P; Vergnenégre A; Robinet G; Léna H; Gervais R; Le Caer H; Souquet PJ; Chavaillon JM; Bozonnat MC; Daurès JP; Chouaid C; Martel-Lafay I;
    Eur J Cancer; 2016 Jan; 52():181-7. PubMed ID: 26689864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical study evaluating dendritic and cytokine-induced killer cells combined with concurrent radiochemotherapy for stage IIIB non-small cell lung cancer.
    Zhu XP; Xu YH; Zhou J; Pan XF
    Genet Mol Res; 2015 Aug; 14(3):10228-35. PubMed ID: 26345959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidation systemic treatment after radiochemotherapy for unresectable stage III non-small cell lung cancer.
    Skrzypski M; Jassem J
    Cancer Treat Rev; 2018 May; 66():114-121. PubMed ID: 29738940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.